{
  "id": "0e22747c0103051598d89b1e7120b71f50462bc6",
  "title": "Greek pharma innovation faces bleak future, industry wants ‘urgent changes’ [Advocacy Lab]",
  "summary_full": "Clawbacks, discontinued therapies, delays, lay-offs and disinvestment have created a concerning pharma business environment in Greece, industry has warned",
  "summary_public": "Clawbacks, discontinued therapies, delays, lay-offs and disinvestment have created a concerning pharma business environment in Greece, industry has warned",
  "url": "https://www.euractiv.com/news/greek-pharma-innovation-faces-bleak-future-industry-wants-urgent-changes/",
  "published_at": "2026-02-23T02:03:11+00:00",
  "source": "Euractiv",
  "language": "en",
  "countries_detected": [
    "GR"
  ],
  "countries_scored": [
    "GR"
  ],
  "llm_version": "v3-eu",
  "llm_perspective": "EU",
  "llm_attempted_at": "2026-02-24T10:07:16+00:00",
  "sentiment_by_country": {
    "GR": {
      "label": "negative",
      "confidence": 0.8,
      "evidence": "Greek pharma innovation faces bleak future, industry wants ‘urgent changes’"
    }
  },
  "processed_at": "2026-02-24T10:07:16+00:00"
}